Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Neurocrine Bioscience buy Citigroup Inc.

Start price
€117.75
29.10.25 / 50%
Target price
€174.28
29.10.26
Performance (%)
15.16%
Price
€135.60
18:27
Summary
This prediction is currently active. The BUY prediction by Citigroup_Inc_ currently has a performance of 15.16%. This prediction currently runs until 29.10.26. The prediction end date can be changed by Citigroup_Inc_ at any time. Citigroup_Inc_ has 50% into this prediction
Performance without dividends (%)
Name 1w
Neurocrine Bioscience 15.16%
iShares Core DAX® -1.602%
iShares Nasdaq 100 -0.781%
iShares Nikkei 225® 1.289%
iShares S&P 500 -0.258%

Comments by Citigroup_Inc_ for this prediction

In the thread Neurocrine Bioscience diskutieren
Prediction Buy
Perf. (%) 15.16%
Target price 174.276
Change
Ends at 29.10.26

Neurocrine Biosciences (NASDAQ:NBIX) had its price target raised by analysts at Citigroup Inc. from $175.00 to $203.00. They now have a "buy" rating on the stock.
Ratings data for NBIX provided by MarketBeat